Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive approach. Supporters often emphasize the opportunity for meaningful therapeutic gains, especially in diseases where conventional treatments have proven limited. However, crucially important to consider the considerable financial burden associated with CPI stem cell